335597 <common-name>9-(2-chlorophenyl)-3-methyl-n-morpholin-4-ylsulfonyl-17-thia-2,4,5,8,14-pentazatetracyclo[8.7.0.02,6.011,16]heptadeca-1(10),3,5,8,11(16)-pentaene-14-carboxamide</common-name> <description>9-(2-chlorophenyl)-3-methyl-n-morpholin-4-ylsulfonyl-17-thia-2,4,5,8,14-pentazatetracyclo[8.7.0.02,6.011,16]heptadeca-1(10),3,5,8,11(16)-pentaene-14-carboxamide is a chemical compound with the formula C23H24ClN7O4S2. With an average molecular weight of 562.10 g/mol, 9-(2-chlorophenyl)-3-methyl-n-morpholin-4-ylsulfonyl-17-thia-2,4,5,8,14-pentazatetracyclo[8.7.0.02,6.011,16]heptadeca-1(10),3,5,8,11(16)-pentaene-14-carboxamide is a heavy molecule.</description> <cas>132418-64-5</cas> <pubchem-id>3076800</pubchem-id> <chemical-formula>C23H24ClN7O4S2</chemical-formula> <weight>562.1</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T17:48:04Z</created-at> <updated-at type="dateTime">2026-08-30T17:48:04Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=NN=C2N1C3=C(C4=C(S3)CN(CC4)C(=O)NS(=O)(=O)N5CCOCC5)C(=NC2)C6=CC=CC=C6Cl</moldb-smiles> <moldb-formula>C23H24ClN7O4S2</moldb-formula> <moldb-inchi>InChI=1S/C23H24ClN7O4S2/c1-14-26-27-19-12-25-21(15-4-2-3-5-17(15)24)20-16-6-7-29(13-18(16)36-22(20)31(14)19)23(32)28-37(33,34)30-8-10-35-11-9-30/h2-5H,6-13H2,1H3,(H,28,32)</moldb-inchi> <moldb-inchikey>FKLMICSXIBTPHY-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">561.1019723</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>1.5</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM331490</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>9-(2-chlorophenyl)-3-methyl-n-morpholin-4-ylsulfonyl-17-thia-2,4,5,8,14-pentazatetracyclo[8.7.0.02,6.011,16]heptadeca-1(10),3,5,8,11(16)-pentaene-14-carboxamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Thienodiazepines</klass> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0286068</sync-id> <structure-inchikey>FKLMICSXIBTPHY-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>20000000001000000000000100000020800000010000200000000000000000000010000000000280420120000000000400000000400400000000000010000000004000004000000000800000208000100000000000080000400000000000000110010000000000010040000000040201001200000202800000000000000000c00000008000000000000000800800000001000000040000000000000000000000000000000800400800000400000000400000000880000000000000800000000000000000000000000008000000100004008020022012000000000000000000000100000000c0000000000440000020000000000040004000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKgAAAIABBgBgAAAAAQMGQCgAAAAD BAdAKAAAAAMDB0AoAAAAAwMGQCgAAAADBAdAKAAAAAMDBkAoAAAAAwQGQCgA AAADBAZAKAAAAAMEBkAoAAAAAwQQQCgAAAADAgYAYAAAAAICBwAoAAAAAwMG AGAAAAACAgYAYAAAAAICBgAoAAAAAwQIACgAAAADAgcAaAAAAAMCARAAIAAA AAYIACgAAAADAggAKAAAAAMCBwAgAAAAAwYAYAAAAAICBgBgAAAAAgIIACAA AAACBgBgAAAAAgIGAGAAAAACAgYAKAAAAAMEBwAoAAAAAwMGAGAAAAACAgZA KAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkAo AAAAAwQRACAAAAABCwABAAECaAwCA2gMAwRoDAQFaAwFBiAGB2gMBwhoDAgJ aAwJCmgMCQsACwwADA0ADQ4ADA8gDxAoAg8RIBESABITCAISFAgCEhUAFRYA FhcAFxgAGBkAGRoABxsgGxwoAhwdABseIB4faAwfIGgMICFoDCEiaAwiI2gM IyQABQFoDB0EAAoGaAwOCAAaFQAjHmgMQgYAAAAFAQIDBAUFCgkIBwYGCwwN DggJBhYXGBkaFQccGwcGBQQdBh8gISIjHhcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:37:17Z</structure-indexed-at> </compound>